Tisotumab Vedotin Efficacious for Recurrent Cervical Cancer
Second- or third-line treatment yields significantly greater efficacy than chemotherapy, including longer overall survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.